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INTRODUCTION
Inhaled histamine is as useful as methacholine for measur-
ing airway responsiveness in asthmatics. However, such side
effects as throat irritation, flushing, and headache are more
frequent with histamine than with methacholine, and are dose-
related (1). It is possible that the inhaled histamine produces
severe adverse effects in asthmatics with increased end organ
responsiveness to histamine.
The pathogenesis of urticaria and angioedema can involve
the release of a diverse array of potential vasoactive mediators
that arise from the activation of cells or enzymatic pathways,
and histamine appears to be the major culprit (2). It has been
reported that skin responses to histamine are enhanced in
patients with chronic idiopathic urticaria (3). Therefore, in-
haled histamine is likely to develop some adverse effects easily
in patients with chronic idiopathic urticaria and/or angioede-
ma. To our knowledge, the patient described herein is the first
case of severe oropharyngeal angioedema developed during
histamine inhalation challenge in an asthmatic patient with
chronic idiopathic angioedema.
CASE REPORT
A 56-yr-old woman visited our clinic for evaluation of chronic
cough and breathlessness. She had experienced mild angioede-
ma episodes involving face and/or extremities without a family
history. The episodes had no clear-cut association with any
food, drugs or physical factors. Nephelometric assays (Behring,
U.S.A.) showed normal C3 (135.4 mg/dL) and C4 (23.3
mg/dL) levels. Radial immunodiffusion assay (Binding Site,
U.K.) showed that C1 esterase inhibitor was 37 mg/dL (normal
range, 15-35 mg/dL). These findings could exclude the diag-
nosis of hereditary angioedema. On visit, she had no angioede-
ma. Spirometry showed 1,980 mL (85% of predicted value)
of forced expiratory volume in one second (FEV1) and 2,550
mL (89%) of forced vital capacity. Skin prick tests with rou-
tine inhalants showed positive responses to Dermatophagoides
pteronyssinus and D. farinae.
Regarding the diagnosis of asthma, methacholine challenge
test was performed according to the standardized tidal breath-
ing method (4). The concentration of methacholine that pro-
duced 20% fall in FEV1 from baseline (PC20) was over 25
mg/mL. Five days later, histamine inhalation challenge test
was performed (4), inhaling doubling concentrations of his-
tamine acid phosphate (Sigma Chemical Co., U.S.A.) from
0.03 to 16 mg/mL. FEV1 fell by 37% from baseline at 3 min
after inhalation of 8 mg/mL, resulting in histamine-PC20 of
4.59 mg/mL. Immediately thereafter, severe angioedema on
face, lips, and oropharyngeal area, foreign body sensation at
throat, and hoarseness occurred (Fig. 1). The angioedema was
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Oropharyngeal Angioedema Induced by Inhaled Histamine
Inhaled histamine used to measure airway responsiveness produces some side
effects more frequently than does methacholine. It is possible that the inhaled his-
tamine induces the side effects in asthmatics with increased end organ responsive-
ness to histamine. A 56-yr-old woman with chronic idiopathic angioedema presented
with asthma-like symptoms. Methacholine challenge test was performed, with a
negative result. Five days later, histamine inhalation test was done. FEV1 fell by 37%
after inhalation of histamine concentration of 8 mg/mL. Immediately thereafter,
severe angioedema on face, lips, and oropharyngeal area, foreign body sensation
at throat, and hoarseness occurred. To assess end organ responsiveness to his-
tamine, skin prick tests with doubling concentrations of histamine (0.03-16 mg/mL)
were carried out on the forearm of the patient and six age- and sex-matched asth-
matic controls. The wheal areas were measured. The patient showed greater skin
responses than the controls. Regression analysis showed that the intercept and
slope were greater than cut-off levels determined from six controls. The patient
showed an increased skin wheal response to histamine, indicating the enhanced
end organ responsiveness to histamine, which is likely to contribute to the devel-
opment of the oropharyngeal angioedema by inhaled histamine.
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apparently observed and spontaneously resolved 4 hr later.
To assess end organ responsiveness to histamine, skin prick
tests with doubling concentrations of histamine from 0.03
to 16 mg/mL were performed in duplicate on the forearm of
the patient and six age- and sex-matched controls with atopic
asthma. All subjects submitted a written consent to partic-
ipate in the study. Fifteen minutes after the histamine prick
test, the wheals corresponding to each of histamine concen-
trations were drawn directly on the arm. Tape was applied,
removed, and glued onto a transparency, permitting an exact
tracing of each area. All areas were calculated after scanning
and integration using the computer program Adobe Photo-
shop and were analyzed using the public domain National
Institutes of Health (NIH) Image program (developed at the
US NIH and available on the Internet at http://rsb.info.nih.
gov/nih.gov/nih-image/). The cut-off value of the skin response
was determined from mean plus 2-fold standard deviation of
wheal area from the controls. The cut-off values for doses of
0.03, 0.06, 0.125, 0.25, 0.5, 1, 2, 4, 8, and 16 mg/mL were
determined as 0, 0, 0, 4.7, 14.2, 15.2, 20.3, 32.0, 54.0, and
62.7 mm2, respectively. The patient showed a greater skin
responses to histamine (6.2, 7.1, 21.2, 22.1, 51.5, and 57.1
mm2 for the doses of 0.125, 0.25, 1, 2, 4, and 8 mg/mL, res-
pectively) than cut-off values (Fig. 2). Also, regression anal-
ysis showed that the intercept (25.9 mm2) and slope (23.0)
were greater than the cut-off values (20.6 mm2 for intercept
and 21.6 for slope) determined from six controls.
DISCUSSION
In the present case, the fact that oropharyngeal angioedema
was induced by histamine, but not by methacholine, suggests
that inhaled histamine is the culprit for the reaction. A vasodi-
lation response of histamine is mediated through both H1and
H2 receptor subtypes, and this response is mediated in part by
endothelium-derived relaxing factor (5). Although side effects
to inhaled histamine are dose-related (1), the histamine concen-
tration (8 mg/mL) producing the oropharyngeal angioedema
in our patient was not very high. This may suggest that the
increased end organ responsiveness to histamine enhances the
effects of histamine at its receptors. Krause and Shuster (3)
reported that the wheal and flare response to histamine was
enhanced in patients with chronic idiopathic urticaria as com-
pared with normal subjects. Similarly, our case of atopic asthma
and chronic idiopathic urticaria showed a greater skin response
to histamine compared with age- and sex-matched atopic asth-
matics, indicating the enhanced end organ responsiveness to
histamine, which may contribute to the occurrence of the
oropharyngeal angioedema by inhaled histamine.
In addition, Kanny et al. (6) showed that abnormal passage
of histamine across the intestinal barrier could result either
from intestinal hyperpermeability and/or a deficit in the enzy-
matic catabolism of histamine in chronic idiopathic urticaria,
postulating a deficit in diamine oxidase in the enterocytes. The
increased absorption of inhaled histamine across the oropha-
ryngeal mucosa may in part play a role in the development of
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Fig. 2. Histamine dose-response curve of the present case (closed
circles) and six controls (open circles). Skin wheal responses
were measured in square millimeters. Error bars represent 2-fold
standard deviation (SD). *means that wheal area of the present
case was greater than the mean +2SD (cut-off values) of that de-
termined from controls.
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Fig. 1. Angioedema on face, lips, and oropharyngeal area devel-
oped immediately after inhalation of histamine concentration of 8
mg/mL.832 Y. Koh, I. Choi
the angioedema in the present case.
Although airway responsiveness to histamine correlated
closely with responsiveness to methacholine (1), our case showed
different airway responses to both stimuli. Spector and Farr (7)
reported that atopic asthmatics were more reactive to histamine
than to methacholine. However, further investigations are
needed to verify this.
Taken together, in case the histamine bronchial provocation
test is performed in asthmatics with a history of chronic idio-
pathic urticaria and/or angioedema, a possibility of severe
oropharyngeal angioedema by inhaled histamine should be
considered.
REFERENCES
1. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Repro-
ducibility and comparison of responses to inhaled histamine and metha-
choline. Thorax 1978; 33: 705-10.
2. Kaplan AP. Urticaria and angioedema. In: Middleton E, Jr. editors,
Allergy: Principles & Practice. St. Louis: Mosby-Year Book, Inc., 1998;
1104-22.
3. Krause LB, Shuster S. Enhanced wheal and flare response to histamine
in chronic idiopathic urticaria. Br J Clin Pharmacol 1985; 20: 486-8.
4. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O’ Byrne PM, Ander-
son SD, Juniper EF, Malo JL. Airway responsiveness. Standardized
challenge testing with pharmacological, physical and sensitizing stim-
uli in adults. Eur Respir J 1993; 6(Suppl 16): 53-83.
5. Dachman WD, Bedarida G, Blaschke TF, Hoffman BB. Histamine-
induced venodilation in human beings involves both H1 and H2 recep-
tor subtypes. J Allergy Clin Immunol 1994; 93: 606-14.
6. Kanny G, Moneret-Vautrin DA, Schohn H, Feldman L, Mallie JP,
Gueant JL. Abnormalities in histamine pharmacodynamics in chronic
urticaria. Clin Exp Allergy 1993; 23: 1015-20.
7. Spector SL, Farr RS. A comparison of methacholine and histamine
inhalations in asthmatics. J Allergy Clin Immunol 1975; 56: 308-16.